Atlas Trials

A Study of Grazoprevir (MK-5172) in Hepatitis C-Infected Male Participants (MK-5172-004)

Clinical trial NCT00998985 · COMPLETED

Trial details

NCT number
NCT00998985
Sponsor
Merck Sharp & Dohme LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatitis C
Start date
2010-02-23
Primary completion
2012-11-08
Enrollment
91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.